Spasticity clinical trials

Explore recruiting spasticity clinical trials.

Recruiting spasticity studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Spasticity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Randomized, Double-Blind, Four-Arm, Placebo-Controlled, Multicenter Study Assessing the Efficacy, Safety and Tolerability of three doses of orally administered BMS-986368, a FAAH/MAGL Inhibitor, for the treatment of Spasticity in Participants with Multiple Sclerosis (BALANCE-MSS-1)

Germany, Czechia, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Complexity-enhancing drugs to treat disorders of consciousness (DoC): a ketamine study

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Riluzole for the treatment of spasticity in the traumatic chronic spinal cord injury condition: Adaptive, Multicenter, placebo-controlled, randomised, double blind trial in a Rare Disorder

France

Phase I and Phase II (Integrated)- Bioequivalence Study EU CTIS Study details

Clinical trial on the effectiveness and safety of botulinum toxin type A (incobotulinumtoxin) in doses adapted to the individual needs of patients with severe spasticity

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Randomized, Single-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Melatonin Administration in Patients With Multiple Progressive Primary Sclerosis (MELATOMS)

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Pulmonary function and sleep related disorders during cervical admission of intrathecal baclofen in spinal cord injury; a safety study

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Spasticity trials by city

Spasticity in Toronto Spasticity in Vancouver Spasticity in Montreal Spasticity in Calgary Spasticity in Edmonton Spasticity in Ottawa Spasticity in Winnipeg Spasticity in Quebec City Spasticity in Hamilton Spasticity in Kitchener Spasticity in London Spasticity in Halifax Spasticity in New York Spasticity in Los Angeles Spasticity in Chicago Spasticity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease